Roots-Analysis-Logo.png
The novel ocular drug delivery devices market is projected to grow at a CAGR of 15%, till 2030, claims Roots Analysis
October 13, 2021 09:30 ET | Roots Analysis
London, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Novel Ocular Drug Delivery Devices Market, 2021 – 2030” report to its list of offerings. Over the years,...
Roots-Analysis-Logo.png
The outsourced cell therapy consumables market is projected to grow at a CAGR of 18% during 2021-2031, claims Roots Analysis
October 12, 2021 08:50 ET | Roots Analysis
London, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Cell Therapy Consumables Market, 2021 – 2031” report to its list of offerings. Currently, more than...
Roots-Analysis-Logo.png
The pharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~7%, till 2030, claims Roots Analysis
October 07, 2021 08:40 ET | Roots Analysis
London, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030” report to its list of offerings. The...
Roots-Analysis-Logo.png
The bioprocess controllers and automation systems market is projected to be grow at an annualized growth rate (CAGR) of 10% by 2030, claims Roots Analysis
October 06, 2021 08:40 ET | Roots Analysis
London, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Bioprocess Controllers and Automation Systems Market, 2021-2030” report to its list of offerings. The...
Roots-Analysis-Logo.png
The novel drug reconstitution systems market, is anticipated to grow a sustained rate, claims Roots Analysis
October 05, 2021 09:00 ET | Roots Analysis
London, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Novel Drug Reconstitution Systems Market, 2021-2030” report to its list of offerings. Given the large...
Roots-Analysis-Logo.png
The vaccine contract manufacturing market is poised to become a multi-billion-dollar market in 2030, growing at an annualized rate of 17.4%, claims Roots Analysis
September 30, 2021 09:00 ET | Roots Analysis
London, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030” report to its list of offerings. Given...
Roots-Analysis-Logo.png
The biospecimen contract research market is projected to grow at a noteworthy pace till 2030, claims Roots Analysis
September 29, 2021 09:00 ET | Roots Analysis
London, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Biospecimen Contract Research Services Market, 2021 – 2030” report to its list of offerings. Given the...
Roots-Analysis-Logo.png
The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers
September 23, 2021 09:00 ET | Roots Analysis
London, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art...
Roots-Analysis-Logo.png
The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis
September 22, 2021 09:00 ET | Roots Analysis
London, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Soft Tissue Sarcoma Market: Focus on Angiosarcoma, Chondrosarcoma, and Liposarcoma Market, 2021-2030” report...
Roots-Analysis-Logo.png
The Fc protein and glyco-engineered antibodies market is projected to grow at a CAGR of over 30% during 2021-2030, claims Roots Analysis
September 14, 2021 08:15 ET | Roots Analysis
London, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Fc Protein and Glyco-engineered Antibodies Market, 2021-2030” report to its list of offerings. Over time, a...